| scholarly article | Q13442814 |
| P50 | author | Barbara Elashoff | Q78010045 |
| Randall C Starling | Q87210023 | ||
| P2093 | author name string | Thomas P Cappola | |
| Gregory A Ewald | |||
| Abdallah G Kfoury | |||
| Allen S Anderson | |||
| Andrew Kao | |||
| David A Baran | |||
| Hannah A Valantine | |||
| James Yee | |||
| Jeffrey J Teuteberg | |||
| Mario C Deng | |||
| Michael X Pham | |||
| Roberta C Bogaev | |||
| William G Cotts | |||
| Helen Baron | |||
| IMAGE Study Group | |||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1890-1900 | |
| P577 | publication date | 2010-04-22 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Gene-expression profiling for rejection surveillance after cardiac transplantation | |
| P478 | volume | 362 |
| Q91744969 | A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy |
| Q84643766 | A noninvasive strategy to monitor rejection in patients with a heart transplant |
| Q92122478 | A qualitative transcriptional signature for the early diagnosis of colorectal cancer |
| Q35007422 | Acute and chronic rejection: compartmentalization and kinetics of counterbalancing signals in cardiac transplants |
| Q47378104 | Acute cellular rejection later than one year after heart transplantation: A single-center retrospective study at Skåne University Hospital in Lund 1988-2010. |
| Q52344790 | Advanced Morphologic Analysis for Diagnosing Allograft Rejection: The Case of Cardiac Transplant Rejection. |
| Q26992073 | Advanced therapies for end-stage heart failure |
| Q28082832 | Advances in the understanding and management of heart transplantation |
| Q37969113 | Antibody-mediated rejection in heart transplantation: case presentation with a review of current international guidelines |
| Q38392458 | Antibody-mediated rejection in pediatric kidney transplantation: pathophysiology, diagnosis, and management |
| Q28716539 | Applications of translational bioinformatics in transplantation |
| Q49834046 | Applying Genomics in Heart Transplantation. |
| Q37204904 | Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events |
| Q92890578 | Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity |
| Q46129739 | Association between preoperative peripheral blood mononuclear cell gene expression profiles, early postoperative organ function recovery potential and long-term survival in advanced heart failure patients undergoing mechanical circulatory support. |
| Q36261525 | Association of Serum MiR-142-3p and MiR-101-3p Levels with Acute Cellular Rejection after Heart Transplantation |
| Q28087434 | Biomarkers as potential treatment targets in inflammatory bowel disease: A systematic review |
| Q38826375 | Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers |
| Q38259358 | Biomarkers in pediatric heart disease |
| Q39128537 | Biomarkers of acute rejection following cardiac transplantation. |
| Q37994305 | Biomarkers of heart transplant rejection: the good, the bad, and the ugly! |
| Q55304599 | Biomarkers to Assess Right Heart Pressures in Recipients of a Heart Transplant: A Proof-of-Concept Study. |
| Q39384930 | Biomarkers to detect rejection after kidney transplantation. |
| Q35471494 | Biomarkers: hopes and challenges in the path from discovery to clinical practice. |
| Q83061459 | CXCL10 and CXCL13 Expression were highly up-regulated in peripheral blood mononuclear cells in acute rejection and poor response to anti-rejection therapy |
| Q92423654 | Cardiac Transplantation: Update on a Road Less Traveled |
| Q92590013 | Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: Validation of a rapid and highly sensitive clinical test for stratification of rejection probability |
| Q42232720 | Challenges and solutions in the development of genomic biomarker panels: a systematic phased approach |
| Q35078413 | Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. |
| Q37179557 | Circulating cytokine portraits can differentiate between allograft rejection and pulmonary infection in cardiac transplant rats |
| Q41772860 | Circulating donor-derived cell-free DNA: a true biomarker for cardiac allograft rejection? |
| Q37241404 | Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II. |
| Q38286234 | Combining genetic and nongenetic biomarkers to realize the promise of pharmacogenomics for inflammatory diseases |
| Q34724232 | Comparison of whole blood and peripheral blood mononuclear cell gene expression for evaluation of the perioperative inflammatory response in patients with advanced heart failure |
| Q56366608 | Complications of Cardiac Transplantation |
| Q26781320 | Computational Models for Transplant Biomarker Discovery |
| Q36186424 | Current genomics in cardiovascular medicine |
| Q27687400 | Current perspectives on systems immunology approaches to rheumatic diseases |
| Q35460974 | Current status of endomyocardial biopsy |
| Q35995043 | Derivation and validation of a cytokine-based assay to screen for acute rejection in renal transplant recipients |
| Q61946036 | Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant |
| Q35558362 | Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis |
| Q51178209 | Differential gene expression profiling in blood from patients with digestive system cancers |
| Q33707373 | Differentially Expressed RNA from Public Microarray Data Identifies Serum Protein Biomarkers for Cross-Organ Transplant Rejection and Other Conditions |
| Q38372764 | Down regulation of protective genes is associated with cellular and antibody-mediated rejection |
| Q35765609 | Emergent Transcriptomic Technologies and Their Role in the Discovery of Biomarkers of Liver Transplant Tolerance |
| Q50148896 | Evaluation of a Machine Learning-Based Prognostic Model for Unrelated Hematopoietic Cell Transplantation Donor Selection |
| Q38106632 | Evaluation of heart failure biomarker tests: a survey of statistical considerations |
| Q35110769 | Functional genomics applied to cardiovascular medicine |
| Q38531858 | Gene Expression Signatures and the Spectrum of Coronary Artery Disease |
| Q26825706 | Gene expression analysis in RA: towards personalized medicine |
| Q82448827 | Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination |
| Q35541507 | Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis |
| Q44810603 | Gene expression profiling of allogeneic islet grafts in an experimental mouse model before rejection or tolerance phenotypes arise |
| Q52626995 | Gene expression profiling scores in dual organ transplant patients are similar to those in heart-only recipients. |
| Q35762677 | Gene expression profiling to study racial differences after heart transplantation |
| Q85109519 | Gene-Expression Profiling after Cardiac Transplantation |
| Q51028254 | General overview of the Seventh International Symposium on Stem Cell Therapy and Cardiovascular Innovations. |
| Q37127078 | Genetics of peripheral artery disease |
| Q94395034 | Genomic Medicine: Why Do "Similar" Patients Have Different Outcomes? |
| Q36837848 | Genomic biomarkers for personalized medicine: development and validation in clinical studies |
| Q91753050 | Heart Transplantation: New Decade, New Perspectives |
| Q38161524 | Heart transplantation in pediatric cardiomyopathies |
| Q36079964 | Human asthma phenotypes: from the clinic, to cytokines, and back again |
| Q37538406 | Humoral immune responses to EGFR-derived peptides predict progression-free and overall survival of non-small cell lung cancer patients receiving gefitinib |
| Q35047164 | Identification and classification of acute cardiac rejection by intragraft transcriptional profiling |
| Q56898193 | Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance |
| Q35072635 | Identification of common blood gene signatures for the diagnosis of renal and cardiac acute allograft rejection |
| Q39029380 | Immunosuppression and adult heart transplantation: emerging therapies and opportunities. |
| Q38184649 | Immunosuppression following heart transplantation: prospects and challenges. |
| Q27010472 | Immunotherapy in gastric cancer |
| Q34436487 | Improved drug therapy: triangulating phenomics with genomics and metabolomics. |
| Q94528590 | In Situ Immune Profiling of Heart Transplant Biopsies Improves Diagnostic Accuracy and Rejection Risk Stratification |
| Q41850141 | Individualized medicine 2010. |
| Q34986281 | Innovative application of immunologic principles in heart transplantation. |
| Q38429229 | Integrative model of leukocyte genomics and organ dysfunction in heart failure patients requiring mechanical circulatory support: a prospective observational study |
| Q36677180 | Integrins α4 and αM, collagen1A1, and matrix metalloproteinase 7 are upregulated in acute Kawasaki disease vasculopathy |
| Q88909731 | Interdisciplinary Models for Research and Clinical Endeavors in Genomic Medicine: A Scientific Statement From the American Heart Association |
| Q27023312 | Issues in solid-organ transplantation in children: translational research from bench to bedside. |
| Q37344517 | Left ventricular myocardial performance index change for detection of acute cellular rejection in pediatric heart transplantation. |
| Q38167057 | Management of the ACC/AHA Stage D patient: cardiac transplantation |
| Q42104515 | Meeting Update: International Society for Heart and Lung Transplantation 2014. |
| Q54148080 | MiR-142-3p is a paracrine mediator between T cells and endothelium during allograft rejection. |
| Q47644374 | MicroRNAs in Heart Failure, Cardiac Transplantation, and Myocardial Recovery: Biomarkers with Therapeutic Potential |
| Q50067434 | Molecular Diagnostic Testing in Cardiac Transplantation |
| Q34553729 | Molecular genetics made simple |
| Q38037357 | Molecular signatures and the study of gene expression profiles in inflammatory heart diseases |
| Q28611470 | Monitoring pharmacologically induced immunosuppression by immune repertoire sequencing to detect acute allograft rejection in heart transplant patients: a proof-of-concept diagnostic accuracy study |
| Q37101630 | Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study |
| Q36206861 | Myocardial Gene Expression Profiling to Predict and Identify Cardiac Allograft Acute Cellular Rejection: The GET-Study |
| Q56991319 | Myocyte growth, repair, and oxidative stress following pediatric heart transplantation |
| Q37994879 | NTproBNP as a marker of rejection in pediatric heart transplant recipients. |
| Q39610198 | New issues in heart transplantation for heart failure |
| Q104748205 | Noninvasive biomarkers for prediction and diagnosis of heart transplantation rejection |
| Q92141812 | Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study |
| Q38566415 | Novel Biomarker Approaches for Managing Patients With Cardiac Transplantation. |
| Q34503698 | Novel diagnostics in renal transplantation |
| Q36477760 | Omics Screening for Pharmaceutical Efficacy and Safety in Clinical Practice |
| Q30487537 | Open access integrated therapeutic and diagnostic platforms for personalized cardiovascular medicine |
| Q57452741 | Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers |
| Q37794226 | Pediatric heart transplantation: demographics, outcomes, and anesthetic implications* |
| Q35801902 | Performance of gene-expression profiling test score variability to predict future clinical events in heart transplant recipients. |
| Q41830012 | Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis |
| Q35073670 | Persistent racial disparities in survival after heart transplantation |
| Q38925305 | Personalized treatment in heart transplantation |
| Q35686793 | Phenotyping patient-derived cells for translational studies in cardiovascular disease |
| Q51328676 | Platelet RNA as a novel biomarker for the response to antiplatelet therapy. |
| Q50908322 | Predictive value of gene expression profiling for long-term survival after heart transplantation. |
| Q37876951 | Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions |
| Q34504281 | Promising new assays and technologies for the diagnosis and management of infectious diseases |
| Q38433502 | Proteoforms in Peripheral Blood Mononuclear Cells as Novel Rejection Biomarkers in Liver Transplant Recipients |
| Q49247828 | Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer |
| Q38418042 | Quasi-random reflections on randomized controlled trials and comparative effectiveness research |
| Q40036192 | RNA Profiling in Human and Murine Transplanted Hearts: Identification and Validation of Therapeutic Targets for Acute Cardiac and Renal Allograft Rejection |
| Q38808790 | Racial and ethnic disparities in outcomes after heart transplantation: A systematic review of contributing factors and future directions to close the outcomes gap. |
| Q45259053 | Radiation exposure after heart transplantation: Trends and significance |
| Q90353213 | Recent advances in heart transplantation |
| Q34183383 | Remote noninvasive allograft rejection monitoring for heart transplant recipients: study protocol for the novel evaluation with home electrocardiogram and remote transmission (NEW HEART) study |
| Q90378296 | Reversible abnormality of electrocardiogram as a sign of acute cardiac rejection after orthotropic heart transplantation |
| Q34492043 | Single-cell transcriptomics: an emerging tool in the study of cardiometabolic disease |
| Q35984536 | Surveillance Endomyocardial Biopsy in the Modern Era Produces Low Diagnostic Yield for Cardiac Allograft Rejection |
| Q34306963 | Systems analysis of oxidant stress in the vasculature |
| Q37295622 | Systems-based approaches to cardiovascular disease |
| Q50057803 | T Cell Dysfunction and Patient Age are Associated with Poor Outcomes after Mechanical Circulatory Support Device Implantation. |
| Q34416724 | Ten years of genetics and genomics: what have we achieved and where are we heading? |
| Q39068970 | Testing the Efficacy of Contrast-Enhanced Ultrasound in Detecting Transplant Rejection Using a Murine Model of Heart Transplantation |
| Q38751217 | The AlloMap™ genomic biomarker story: 10 years after |
| Q28085440 | The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ Transplantation |
| Q55437542 | The Past, Present and Future of Heart Transplantation. |
| Q28075045 | The Role of Laboratory Tests in Crohn's Disease |
| Q52680424 | The future of cardiac transplantation. |
| Q38035388 | The future of heart transplantation |
| Q41875427 | The natural history of biopsy-negative rejection after heart transplantation |
| Q38121720 | Therapeutic implications of biomarkers in chronic heart failure |
| Q48618416 | Three-Dimensional Speckle-Tracking Echocardiographic Monitoring of Acute Rejection in Heart Transplant Recipients |
| Q37844547 | Transcriptional profiling to identify biomarkers of disease and drug response |
| Q36126740 | Transcriptomic biomarkers for the accurate diagnosis of myocarditis |
| Q39175303 | Transplant genetics and genomics |
| Q34794715 | Universal noninvasive detection of solid organ transplant rejection |
| Q40053821 | Urinary Proteomics in Predicting Heart Transplantation Outcomes (uPROPHET)-Rationale and database description. |
| Q41445261 | Use of [18F]FDG Positron Emission Tomography to Monitor the Development of Cardiac Allograft Rejection |
| Q30486678 | Utility of Gene Expression Profiling Score Variability to Predict Clinical Events in Heart Transplant Recipients |
| Q36684948 | VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients |
| Q34257142 | Value of the first post-transplant biopsy for predicting long-term cardiac allograft vasculopathy (CAV) and graft failure in heart transplant patients |
| Q47363779 | Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients |
| Q83390594 | [Heart transplantation. Pathology, clinical work-up and therapy] |
Search more.